Literature DB >> 23661467

ATP-dependent chromatin remodeling and histone acetyltransferases in 5-FU cytotoxicity in Saccharomyces cerevisiae.

R Matuo1, F G Sousa, D Bonatto, A A Mielniczki-Pereira, J Saffi, D G Soares, A E Escargueil, A K Larsen, J A P Henriques.   

Abstract

Chromatin is thought to modulate access of repair proteins to DNA lesions, and may be altered by chromatin remodelers to facilitate repair. We investigated the participation of chromatin remodelers and DNA repair in 5-fluorouracil (5-FU) cytotoxicity in Saccharomyces cerevisiae. 5-FU is an antineoplastic drug commonly used in clinical settings. Among the several strains tested, only those with deficiencies in ATP-dependent chromatin remodeling (CR) and some histone acetyltransferases (HAT) exhibited sensitivity to 5-FU. CR and HAT double-mutants exhibited increased resistance to 5-FU in comparison to the wild-type mutant, but were still arrested in G2/M, as were the sensitive strains. The participation of Htz1p in 5-FU toxicity was also evaluated in single- and double-mutants of CR and HAT; the most significant effect was on cell cycle distribution. 5-FU lesions are repaired by different DNA repair machineries, including homologous recombination (HR) and post-replication repair (PRR). We investigated the role of CR and HAT in these DNA repair pathways. Deficiencies in Nhp10 and CR combined with deficiencies in HR or PRR increased 5-FU sensitivity; however, combined deficiencies of HAT, HR, and PRR did not. CRs are directly recruited to DNA damage and lead to chromatin relaxation, which facilitates access of HR and PRR proteins to 5-FU lesions. Combined deficiencies in HAT with defects in HR and PRR did not potentiate 5-FU cytotoxicity, possibly because they function in a common pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23661467     DOI: 10.4238/2013.April.26.6

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  4 in total

1.  Chromosome segregation and organization are targets of 5'-Fluorouracil in eukaryotic cells.

Authors:  Laura Mojardín; Javier Botet; Sergio Moreno; Margarita Salas
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Heterochromatin Protein 1 Binding Protein 3 Expression as a Candidate Marker of Intrinsic 5-Fluorouracil Resistance.

Authors:  Jamie N Hadac; Devon D Miller; Ian C Grimes; Linda Clipson; Michael A Newton; William R Schelman; Richard B Halberg
Journal:  Anticancer Res       Date:  2016-03       Impact factor: 2.480

3.  Genomic alterations in DNA repair and chromatin remodeling genes in estrogen receptor-positive metastatic breast cancer patients with exceptional responses to capecitabine.

Authors:  Maren K Levin; Kai Wang; Roman Yelensky; Ying Cao; Corinne Ramos; Nicholas Hoke; John Pippen; Joanne L Blum; Barry Brooks; Gary Palmer; Norma Palma; Sohail Balasubramanian; Jeffrey S Ross; Joyce O'Shaughnessy
Journal:  Cancer Med       Date:  2015-04-13       Impact factor: 4.452

4.  Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer: A case report.

Authors:  Giacomo Barchiesi; Eriseld Krasniqi; Maddalena Barba; Marina Della Giulia; Laura Pizzuti; Gioia Massimiani; Gennaro Ciliberto; Patrizia Vici
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.